Intracoronary ultrasound assessment of morphological and functional abnormalities associated with cardiac allograft vasculopathy.
- 1 January 1994
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 89 (1) , 272-277
- https://doi.org/10.1161/01.cir.89.1.272
Abstract
BACKGROUND The diffuse nature of cardiac allograft vasculopathy makes early detection of the disease by traditional noninvasive methods or coronary angiography difficult. The aim of this study was to determine if there is a relation between abnormalities in vessel wall morphology, as assessed by intracoronary ultrasound, and a decreased vasodilatory response to the endothelium-dependent vasodilator papaverine hydrochloride and if cardiac allograft vasculopathy detected by coronary angiography is associated with specific intracoronary ultrasound findings. METHODS AND RESULTS Twenty-three heart transplant recipients underwent 25 intracoronary ultrasound studies and 24 studies of coronary vasomotor tone 10 days to 8.3 years after surgery using a 20-mHz intracoronary ultrasound catheter. The studies were divided in two groups according to the presence (n = 7, group 1) or absence (n = 18, group 2) of angiographically evident cardiac allograft vasculopathy. Qualitative assessment of vessel wall morphology and quantitative analysis of the vasodilator response to the injection of papaverine hydrochloride into the coronary artery distal to the imaging site were performed off-line, and results for the two study groups were compared. A significantly higher percentage of patients with than without angiographic evidence of cardiac allograft vasculopathy had a three-interface vessel wall morphology by intracoronary ultrasound (100% versus 11%, P < .001). In two recipients who underwent two serial studies, the appearance of three interfaces in the vessel wall or a progressive thickening of the inner interface of the vessel wall occurred in conjunction with the appearance of angiographic cardiac allograft vasculopathy. The vasodilator response to papaverine was less in patients with than in those without angiographically evident cardiac allograft vasculopathy both in terms of absolute and relative increases in lumen diameter (+0.1 +/- 0.12 mm versus +0.3 +/- 0.17 mm, P < .05, and +5.1 +/- 5.3% versus +8.2 +/- 5.3%, P = NS) and lumen cross-sectional area (+0.5 +/- 0.6 mm2 versus +1.7 +/- 1.1 mm2, P < .02, and +7.1 +/- 8.8% versus 16.6 +/- 11.0%, P = .055), respectively. CONCLUSIONS Intracoronary ultrasound assessment of vessel wall morphology and evaluation of vascular response to endothelium-dependent vasodilators are useful techniques for detecting cardiac allograft vasculopathy.Keywords
This publication has 11 references indexed in Scilit:
- Intravascular ultrasound imaging of angiographically normal coronary arteries: An in vivo comparison with quantitative angiographyJournal of the American College of Cardiology, 1991
- Transplant coronary artery disease: Histopathologic correlations with angiographic morphologyJournal of the American College of Cardiology, 1991
- Diagnosis and Management of Graft Atherosclerosis (Chronic Rejection)Published by Springer Nature ,1990
- Accelerated coronary vascular disease in the heart transplant patient: Coronary arteriographic findingsJournal of the American College of Cardiology, 1988
- Videodensitometric analysis of human coronary stenoses: validation in vivo by intraoperative high-frequency epicardial echocardiography.Circulation, 1988
- Responses of coronary arteries of cardiac transplant patients to acetylcholine.Journal of Clinical Investigation, 1988
- Single stretch-activated ion channels in vascular endothelial cells as mechanotransducers?Nature, 1987
- Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1986
- Crucial role of endothelium in the vasodilator response to increased flow in vivo.Hypertension, 1986
- Flow-Dependent, Endothelium-Mediated Dilation of Epicardial Coronary Arteries in Conscious DogsJournal of Cardiovascular Pharmacology, 1984